EYE TECH CARE receives CFDA Approval for its EyeOP1 glaucoma treatment product
Award-winning medical technology company EYE TECH CARE has received approval from the China Food and Drug Administration (CFDA) to begin marketing its EyeOP1® glaucoma treatment product in [...]
WGC Symposium - Feedback
A few words to share feedback on the recent World Glaucoma Congress that took place in Helsinki on June 28th-July 1st.
• Communications 6 communications as oral posters presented on June 29th [...]
Interview from Prof. Stalmans about UCP procedure
Interview from Ingeborg Stalmans is online on The Ophthalmologist website! In this video, Pr Stalmans shares her experience with the product, key benefits she sees in the technology and her [...]
Technology Innovation Award
London – 9 January 2017 – Based on its recent analysis of the glaucoma therapy market, Frost & Sullivan recognizes EYE TECH CARE with the 2016 Europe Award for Technology Innovation for [...]
Publication of Meta-analysis in European Ophthalmic Review
Professor Philippe Denis, Chairman of French Glaucoma Society presents the results of a meta-analysis from 7 clinical studies, with 251 patients (53% had refractory glaucoma and 47% were naïve [...]
Important funding and partnership agreement with EVERPINE Capital
Funds will be used to strengthen the business development of the company in Europe and to pursue market access in China.EYE TECH CARE announced that it has secured a new round of funding [...]
EYE TECH CARE launches its operations in China
Award of Medical Device classification from China Food and Drug Administration for EyeOP1 Beginning of approval process
EYE TECH CARE announced the launch of the approval process in China for [...]
EYE TECH CARE presents its new generation probe
On the occasion of the 121st annual congress of the SFO (Société Française d’Ophtalmologie), May 9 to 12, in Paris, EYE TECH CARE presents its “new generation probe”.
With the recent [...]
CE mark extension
EYE TECH CARE focused ultrasound treatment device gains CE mark extension to treat surgery-naive glaucoma
Use of the EyeOP1® device is now open to less advanced glaucoma
Rillieux-la-Pape, [...]
EYE TECH CARE Science start-up of the year 2014
EYE TECH CARE awarded Falling Walls Science Start-up of the YearBerlin, 9 November 2014. More than 25 outstanding science based start-up companies from around the world presented their [...]
